Skip to content Skip to footer

International Cannabis Weekly: 314

September 1, 2023

Highlights

Share this story
Highlights

TOP US HEALTH OFFICIALS RECOMMEND RESCHEDULING CANNABIS

In a historical development the US Department of Health and Human Services has recommended that cannabis be reclassified as a lower risk drug to Schedule III.

READ MORE  »

PHARMACEUTICAL CANNABIS PLAYERS ARE DRIVING TECHNOLOGICAL INNOVATION

READ MORE »

NEW YORK BRINGS CANNABIS LICENSING PROCESS TO A COMPLETE HALT

READ MORE »

Highlights

Share this story
Europe
  • UK Home Office urged to provide greater clarity and protection for CBD industry through enhanced regulations.
  • Strong indications that medical cannabis legalisation will make its way into France’s 2024 annual budget.
  • Mamedica partners with Cantourage to launch the first of its own-brand strains of Canadian THC-dominant cannabis in UK.
  • Amsterdam’s Ministry of Justice provides update in regards to cannabis trial in East district.
  • SOMAÍ Pharmaceuticals receives EU-GMP Certification and raises €5 million to fund ambitious growth plans.
  • Denmark’s DanCann Pharma announces the issuance of new shares as part of debt conversion.

Highlights

Share this story
Stocks

Highlights

Share this story
United States

Highlights

Share this story
New Report

Highlights

Share this story
Canada
  • Canadian cannabis companies turn to international medical cannabis market, seeing exports increase by 50% last year.
  • Recent report states Canada’s cannabis market is showing steady growth but lags behind US counterparts.
  • Tilray Brands debuts its new ‘Diamonds Collection’ by its premium cannabis lifestyle brand RIFF.
  • Calgary’s Decibel Cannabis Company enters into a supply agreement with UK’s 4C LABS.
  • Vancouver’s Digicann Ventures announces sale of investment for gross proceeds of C$225,000.
  • Toronto’s Entourage Health reports second quarter financial results recording total revenue of C$13.37 million.

Highlights

Share this story
Upcoming Event

Highlights

Share this story
LATAM & The Caribbean

Highlights

Share this story
APAC

Highlights

Share this story
Africa & The Middle East
  • Cannabis is illegal in Nigeria but provides a living for families: Study calls for reevaluation of drug laws.
  • Israel’s Innocan Pharma study shows reduced osteoarthritis pain in dogs after CBD injection.
Latest Issues

Insights

on the global cannabis industry

International Cannabis Weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry. Join our community of 80,000+ subscribers.